Targeted molecular therapy is considered as an efficient method for RCC metastasis treatment, and some targeted molecular, like mTOR inhibitor (temsirolimus) and VEGF (bevacizumab), have been proved to be clinically efficient for RCC treatment 4, 5. Here, MTOR is linked to renal cell carcinoma.